SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Feller Faye (Last) (First) (Middle) C/O GERON CORPORATION 919 E HILLSDALE BLVD. SUITE 250 (Street) FOSTER CITY CA 94404 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 07/09/2022	3. Issuer Name and Ticker or Trading Symbol GERON CORP [ GERN ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) EVP, Chief Medical Officer	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	04/17/2019(1)	04/16/2029	Common Stock	400,000(1)	$1.74	D
Stock Options (right to buy)	04/17/2019(2)	04/16/2029	Common Stock	80,000(2)	$1.74	D
Stock Options (right to buy)	02/12/2020(3)	02/11/2030	Common Stock	155,400(3)	$1.295	D
Stock Options (right to buy)	02/02/2021(4)	02/01/2031	Common Stock	155,400(4)	$2.055	D
Stock Options (right to buy)	02/16/2022(5)	02/15/2032	Common Stock	200,000(5)	$1.06	D

Explanation of Responses:

1. This option vests as follows: 50,000 shares on October 8, 2019, the remaining 350,000 shares in a series of 42 equal monthly installments commencing October 8, 2019, provided the optionee continues to provide services to the Company.

2. This option vests in 3 years on April 8, 2022, provided the optionee continues to provide services to the Company.

3. This option vests in a series of 48 consecutive equal monthly installments commencing on February 12, 2020, provided the optionee continues to provide services to the Company.

4. This option vests in a series of 48 consecutive equal monthly installments commencing on February 2, 2021, provided the optionee continues to provide services to the Company.

5. This option vests in a series of 48 consecutive equal monthly installments commencing on February 16, 2022, provided the optionee continues to provide services to the Company.

	/s/ Olivia Bloom for Faye Feller	07/12/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.